If contrast-enhanced CT cannot be used, which imaging modality is preferred to evaluate a suspected RCC?

• A. Ultrasound
• B. MRI
• C. X-ray
• D. CT abdomen with contrast; MRI if contrast contraindicated

Answer: (B)

When a contrast-enhanced CT cannot be used, MRI is the preferred way to evaluate a suspected renal cell carcinoma because it provides superior soft-tissue contrast and multiplanar imaging that helps precisely characterize a renal mass and assess its extent. Dynamic contrast-enhanced MRI reveals how the lesion enhances over time, which helps distinguish malignant solid tumors from benign cystic or fat-containing lesions. MRI is also excellent for staging, offering detailed assessment of involvement of the renal vein, IVC, and surrounding structures, which is crucial for planning treatment. It avoids ionizing radiation and, with gadolinium-based contrast (when not contraindicated), gives multiple complementary sequences—like diffusion-weighted imaging—that improve lesion characterization. If gadolinium cannot be used, noncontrast MRI sequences can still help, but overall reliability is best with contrast-enhanced MRI.